Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: Design of a multicenter randomized controlled trial

Trials

Volumn 11, Issue , 2010, Pages

  Chen, Rixin ^a   Chen, Mingren ^a   Xiong, Jun ^a   Yi, Fan ^b   Chi, Zhenhai ^a   Zhang, Bo ^a  

^a The Affiliated Hospital of Jiangxi University of TCM   (China)

^b Department of Health of Jiangxi Province ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; SALMETEROL XINAFOATE; ANDROSTANE DERIVATIVE; DRUG DERIVATIVE; FLUTICASONE, SALMETEROL DRUG COMBINATION; SALBUTAMOL;

ADULT; ALLOPATHY; ARTICLE; ASTHMA; CHINA; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HEAT SENSITIVITY; HUMAN; MALE; MOXIBUSTION; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADOLESCENT; AGED; CHRONIC DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; METHODOLOGY; MIDDLE AGED; SAMPLE SIZE;

ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ASTHMA; CHRONIC DISEASE; CLINICAL PROTOCOLS; DRUG COMBINATIONS; HUMANS; MIDDLE AGED; MOXIBUSTION; RESEARCH DESIGN; SAMPLE SIZE;

EID: 78650045725     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-121     Document Type: Article

References (39)

1. Global Initiative for Asthma (GINA) Global strategy for asthma man- agement and prevention: NHLBI/WHO Workshop Report. 2002, Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute, Global Initiative for Asthma (GINA).
2. National Asthma Education and Prevention Program Guidelines for the diagnosis and management of asthma: expert panel report 2. 1997, 97-4051. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute, National Asthma Education and Prevention Program.
3. Masoli M, Fabian D, Holt S. Beasley Rather global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2005, 59:469-478.
4. Anderson HR, Gupta R, Strachan DP, Limb ES. "50 years of asthma: UK trends from 1955 to 2004". Thorax 2007, 62:85-90. 10.1136/thx.2006.066407, 2111282, 17189533.
5. World Health Organization Fact Sheet Fact sheet No 307: Asthma (2009). Accessed 08-05-10., http://www.who.int/mediacentre/factsheets/fs307/en/print.html
6. Global Initiative for Asthma Global strategy for asthma management and prevention. 2004, NIH publication, Global Initiative for Asthma.
7. Salpeter S, Buckley N, Ormiston T, Salpeter E. "Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths". Ann Intern Med 2006, 144:904-912.
8. Blanc PD, Trupin L, Earnest G, Katz PP, Yelin EH, Eisner MD. "Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: data from a population-based survey". Chest 2001, 120:1461-1467. 10.1378/chest.120.5.1461, 11713120.
9. Shenfield G, Lim E, Allen H. "Survey of the use of complementary medicines and therapies in children with asthma". J Paediatr Child Health 2002, 38:252-7. 10.1046/j.1440-1754.2002.00770.x, 12047692.
10. Cho ZH, Hwang SC, Wong EK, Son YD, Kang CK, Park TS, Bai SJ, Kim YB, Lee YB, Sung KK. Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms. Acta Neurol Scand 2006, 113:370-377. 10.1111/j.1600-0404.2006.00600.x, 16674603.
11. Peng ZF, Zhao JS, Yang F, Wang Y, Zhang LJ, Ran SQ. Progresses of studies on disease factors influencing the therapeutic effect of acupuncture and moxibustion on bronchial asthma. Zhongguo Zhen Jiu 2009, 29:72-76.
12. Liu A. Clinical application of moxibustion over point dazhui. J Tradit Chin Med 1999, 19:283-286.
13. Zhou D, Yang S. Effective observation on purulent moxibustion in treating 106 cases of bronchial asthma. Zhen Ci Yan Jiu 1992, 17:239-241.
14. Hong H. Analysis to influence of purulent moxibustion on bronchial asthma. Zhen Ci Yan Jiu 1992, 17:237-239.
15. McCarney RW, Brinkhaus B, Lasserson TJ, Linde K. Acupuncture for chronic asthma. Cochrane Database of Systematic Reviews 2003, (3):CD000008.
16. Jobst KA. A critical analysis of acupuncture in pulmonary disease: efficacy and safety of the acupuncture needle. Journal of Alternative and Complementary Medicine 1995, 1:57-84.
17. Linde K, Worku F, Stör W, Wiesner-Zechmeister M, Pothmann R, Weinschütz T. Randomized clinical trials of acupuncture for asthma - a systematic review. Forsch Komplementarmed 1996, 3:148-155.
18. Martin J, Donaldson AN, Villarroel R, Parmar MK, Ernst E, Higginson IJ. Efficacy of acupuncture in asthma: systematic review and meta-analysis of published data from 11 randomized controlled trials. European Respiratory Journal 2002, 20:846-852. 10.1183/09031936.02.00078702, 12412674.
19. Ayman E, Karl O. Moxibustion in Breech Version-A Descriptive Review. Acupuncture in medicine 2002, 20:26-29. 10.1136/aim.20.1.26, 11926602.
20. Chen RX, Kang MF. Clinical application of acupoint heat-sensitization. Zhongguo Zhenjiu 2007, 27:199-202.
21. Chen RX, Kang MF. Key point of moxibustion, arrival of qi produces curative effect. Zhongguo Zhen Jiu 2008, 28:44-46.
22. Chen RX, Kang MF, He WL, Chen SY, Zhang B. Moxibustion on heat-sensitive acupoints for treatment of myofascial pain syndrome: a multi-central randomized controlled trial. Zhongguo Zhen 2008, 28:395-398.
23. Chen RX, Kang MF. Acupoint heat-sensitization moxibustion: a new therapy. 2006, Press by People's Medical Publishing House. Beijing in China, 1.
24. Tang FY, Huang CJ, Chen RX, Xu M, Liu BX, Liang Z. Observation on therapeutic effect of moxibustion on temperature-sensitive points for lumbar disc herniation. Zhongguo Zhen Jiu 2009, 29:382-384.
25. Zhang C, Xiao H, Chen R. Observation on curative effect of moxibusting on heat-sensitive points on pressure sores. China Journal of Traditional Chinese Medicine and Pharmacy 2010, 25:478-488.
26. Kang MF, Chen RX, Fu Y. Observation on curative effect of moxibusting on heat-sensitive points on knee osteoarthritis. Jiangxi Journal of Traditional Chinese Medicine and Pharmacy 2006, 18:27-28.
27. Global Initiative for Asthma (GINA) Pocket guide for asthma manage-ment and prevention. 1998, Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute; Publication No. 95-3659B, Global Initiative for Asthma (GINA).
28. Eric BD, Homer BA, Jean B, William BW, Clark TJH, Romain PA, Søren E, . Pedersen for the GOAL. Investigators Group Can Guideline-defined Asthma Control Be Achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004, 170:836-844. 10.1164/rccm.200401-033OC, 15256389, Pedersen for the GOAL. Investigators Group.
29. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3 2007). NIH Item No. 08-4051. Accessed September 10, 2007., US Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute., http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
30. Lababidi H, Hijaoui A, Zarzour M. Validation of the Arabic version of the asthma control test. J Allergy Clin Immunol 2004, 113:59-65. 10.1016/j.jaci.2003.09.008, 14713908.
31. Liu B, Wen T, Yao C, Yan S, He L, Xie Y, Mu Z. The central randomization system in multi-center clinical trials. Chin J New Drugs Clin Rem 2006, 12:931-935.
32. Asthma group of Chinese Society of Respiratory Diseases The guideline of asthma treatment and prevention. Clin J Tuberc Respir Dis 1997, 20:261-267. Asthma group of Chinese Society of Respiratory Diseases.
33. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited study group. Lancet 1994, 344:219-24. 10.1016/S0140-6736(94)92996-3, 7913155.
34. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol 1999, 82:383-9. 10.1016/S1081-1206(10)63288-7, 10227337.
35. Pauwels TA, Lofdahl C-G, Postma DS, Pride NB, Ohlsson SV. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997, 337:1405-11. 10.1056/NEJM199711133372001, 9358137.
36. Vanden Berg NJ, Ossip M, Hederos CA, Antilla H, Ribeiro BL, Davies PI. Salmeterol/fluticasone propionate (50/100 mcg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Paed Pulmonol 2000, 30:97-105.
37. Zetterström O, Buhl R, Mellem H, Perpina M, Hedman J, O'Neill S, Ekstrom T. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001, 18:262-8.
38. Tal A, Simon G, Vermeulen JH, Petru V, Cobos N, Everard ML, De Boeck K. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol 2002, 34:342-50. 10.1002/ppul.10173, 12357478.
39. Ernst E. Complementary therapies for asthma: what patients use?. J Asthma 1998, 35:667-71. 10.3109/02770909809048969, 9860087.